Category

Global Organoid Technology Market Size, Share, Opportunities And Trends By Type (Cerebral, Thyroid, Thymic, Testicular, Hepatic, And Other Organoids), By Application (Research, Drug Discovery, Tissue Engineering, Stem Cell Biology, And Other Applications), By End User (Research Laboratories And Institutes, Biotechnology And Pharmaceutical Companies, And Hospitals And Diagnostic Centers), And By Geography - Forecasts From 2019 To 2024

Published: Mar 2020 | Report Code:  KSI061611198 | Pages:  90

Global organoid technology market is projected to grow at a CAGR of 28.11% during the forecast period. Organoid technology refers to the growing of organs or ‘mini-organs’ under lab conditions. It is also referred to as 3D cell culture technology which leads to organ formation useful to replace, repair or regenerate any diseased tissue or organs and holds a promising future in cancer and biomedical research.

The organoid technology market is driven by the significant growth in the healthcare industry across the globe. The ethical concerns regarding animal testing is a supportive factor for the market as the technology does not involve any animal testing. Huge investments from the major market players into research and development activities to make the technology more advanced and reliable is augmenting the growth of the market. With the increasing R&D activities in the field of stem cells and regenerative medicine and the advancement in stem cell research is further fueling the growth of the market across the globe. Furthermore, the increasing investment in the pharmaceutical industry for the development of new and innovative products is also attributing to the demand in the forecast period.

However, rising availability for substitutes for organoid technology due to technological advancements may hamper the growth of the market. Moreover, the high cost of drug testing procedures and lack of skilled professionals may also act as a restraining factor in the market.

Geographically, North America holds a significant share owing to the presence of major market players and in the region and their increasing expenditure on R&D. Europe also holds a significantly large share in the global market on account of state-of-the-art research facilities in this region.

Industry Update

In March 2019, JSR Corporation partnered with Hubrecht Organoid Technology (HUB) which will allow the former to access HUB’s highly-characterized tumor organoid biobank. 

In March 2018, the MDI Biological Laboratory in Bar Harbour, Maine partnered with Hubrecht Organoid Technology (HUB) to offer a one-week intensive course to offer basics of organoid culture and the most recent developments in the organoid field to both students and researchers.

The major players profiled in the Global Organoid Technology market include Cellesce Ltd, StemCell Technologies, Organoid Technologies GmbH, QGel SA, Trevigen Inc., and CORNING Incorporated among others.

Segmentation:

By Type 

Cerebral Organoid

Thyroid Organoid

Thymic Organoid

Testicular Organoid

Hepatic Organoid

Others

By Application

Cancer Research

Biomedical Research

Regenerative Medicine

Personalized Medicine

By Geography

North America

USA

Canada

South America

Europe

Germany

France

United Kingdom

Middle East and Africa

Asia Pacific

China

Japan

Australia


Frequently Asked Questions (FAQs)

Q1. What are the growth prospects for the organoid technology market?
A1. The organoid technology market is expected to grow at a CAGR of 28.11% over the forecast period.
 
Q2. How is the organoid technology market segmented?
A2. The organoid technology market has been segmented by type, application, and geography.
 
Q3. Who are the major players in the organoid technology market?
A3. Some of the major players in the organoid technology market are Cellesce Ltd, StemCell Technologies, Organoid Technologies GmbH, QGel SA, Trevigen Inc., and CORNING Incorporated among others.
 
Q4. What factors are anticipated to drive the organoid technology market growth?
A4. The growth of the organoid technology market is driven by significant growth in the healthcare industry across the globe.
 
Q5. Which region holds the largest market share in the organoid technology market?
A5. North America holds a significant share owing to the presence of major market players and in the region and their increasing expenditure on R&D. Europe also holds a significantly large share in the global market on account of state-of-the-art research facilities in this region.
 

Explore custom options available with this study:

  • Request customization

  • Buy sections of the study

  • Buy country specific report

  • Request excel, Historical data

  • Subscription inquiry

  • Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.

Confidentiality

We are in compliance with the global privacy laws.

OUR CLIENTS